Eagle’s Eye View: Inflammation and Cholesterol are Predictors of CV Events
Release Date:
In this week's View, Dr. Eagle looks at a collaborative analysis of three randomized trials that investigated inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy. He then covers the 2023 ACC Expert Consensus Decision Pathway on Management of Heart Failure with Preserved Ejection Fraction. Finally, Dr. Eagle explores ACTIVE-AF, a randomized controlled trial on exercise and physical activity program in patients with atrial fibrillation. Subscribe to Eagle’s Eye View
Eagle’s Eye View: Inflammation and Cholesterol are Predictors of CV Events